USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences Funding in Europe 2005 (Phase I) - Sources of Funding
Life Sciences Funding in Europe 2005 (Phase I) - Sources of Funding
RELEASE DATE
01-Sep-2005
01-Sep-2005
REGION
Europe
Europe
Research Code: B646-01-00-00-00
SKU: HC01113-EU-MR_05182
$6,950.00
Special Price $5,212.50 save 25 %
In stock
SKU
HC01113-EU-MR_05182
Description
This research service examines and monitors life science funding trends in Europe. Funding analysis and challenges are discussed for United Kingdom, Germany and France and from the European Commission's perspective.
Table of Contents
Snapshot of the Life Sciences Funding in Europe
- Executive Summary
Glossary of Terms
- Glossary
Exchange Rates
- Exchange Rates
Assumptions and Methodology
Funding Overview
Market Engineering Measurements
- Funding Landscape - The European Commission
Challenges
- Market Engineering Measurements
Funding Analysis
- Funding Challenges
Overview
Market Engineering Measurements
Funding Analysis
Overview
Market Engineering Measurements
Funding Analysis
Overview
Market Engineering Measurements
Funding Analysis
Private Investment in Biotechnology
Number of Biotechnology Companies
Government R&D Investment in Biotechnology
Pharmaceutical R&D Expenditure
Pharmaceutical R&D Expenditure as a per cent of Pharmaceutical Market
This research service examines and monitors life science funding trends in Europe. Funding analysis and challenges are discussed for United Kingdom, Germany and France and from the European Commission's perspective.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | B646-01-00-00-00 |
| Is Prebook | No |